![]() Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | |||
Founding Date | Founding Date 2001 | Founding Date 2007 | Founding Date 2020 |
Type | Type Subsidiary | Type Private | Type Private |
Tags | |||
Locations | Locations Gent, BE HQ | Locations Tres Cantos, ES HQ | Locations Rockville, US HQ Cambridge, US |
Employees | Employees 1252% decrease | Employees 28 | Employees 502% increase |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 9.4m (about 14 years ago) | Latest funding round $ 150m (over 2 years ago) |
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 9.4m | Total funding raised $ 150m |

Vivia Biotech is a company specializing in providing individualized medicine.
View company
Clasp Therapeutics is a company that provides immuno-oncology solutions.
View company